|
> Home page
Beta cells: Another cure
for Type 1 diabetes ... in mice
By Christine Cotter / Los Angeles Times
(c)
NO ADSENSE ACCOUNT SELECTED FOR GOOGLE ADSENSE
Scientists have been searching for a way
to cure Type 1 diabetes by regenerating the insulin-producing
beta cells in the pancreas that are lost in the disease.
Without them, the body is unable to metabolize sugar, forcing
patients to compensate by injecting themselves with insulin
several times a day.
One popular strategy has been
to try to get embryonic stem cells or induced pluripotent
stem cells -- which can theoretically become any type of
human cell -- to grow into the beta cells that diabetes
patients need. Last year researchers from Harvard
University took a huge shortcut and transformed normal
pancreas cells into the coveted beta cells by activating a
trio of dormant genes.
Insulin2 Today a team of European and
American researchers report that pancreatic cells in diabetic
mice could be reprogrammed into beta cells by turning on just
one gene, called Pax4.
The scientists gave the mice a drug
called streptozotocin that killed off their beta cells while
preserving other types of pancreatic cells. Then they activated
the Pax4 gene, which does most of its work during fetal
development.
NO ADSENSE ACCOUNT SELECTED FOR GOOGLE ADSENSE They found that the
gene converted so-called alpha cells -- which normally made a
hormone called glucagon -- into beta cells that made insulin.
Beta cell levels were eight times higher in treated mice than
in untreated control subjects, according to the study being
published in Friday’s edition of the journal Cell.
For some reason that the researchers
don’t yet understand, the therapy worked best on mice that were
less than one month old. For them, the treatment completely
counteracted the symptoms of Type 1 diabetes.
In fact, it may have worked too well,
leaving the mice with a shortage of alpha cells. Before this
approach can be tried in humans, scientists will need to figure
out a safe way to turn on the Pax4 gene -- and then find a way
to shut it off.
“A lot of 'ifs' remain before we will
know whether it could be taken to the clinic,” said the study’s
lead author, Patrick Collombat, a researcher at the Max Planck
Institute for Biophysical Chemistry in Germany. But for Type 1
diabetes patients who are currently treated with daily insulin
injections, he said in a statement, this much is clear: “We
need a better treatment. We need to find a way to regenerate
beta cells.”
For more information:
Christine Cotter / Copyright 2009 Los Los Angeles Times
http://latimesblogs.latimes.com/booster_shots/2009/08/type-1-diabetes-beta-cell-therapy.html
|